General
Preferred name
LEVOCARNITINE PROPIONATE HYDROCHLORIDE
Synonyms
Propionyl-L-carnitine hydrochloride ()
L-Propionylcarnitine chloride ()
ST-261 ()
Levocarnitine propionate (hydrochloride) ()
L-Propionylcarnitine (chloride) ()
Propionyl-L-carnitine (chloride) ()
Dromos ()
NSC-759826 ()
Levocarnitine propionate hcl ()
ST 261 ()
Propionyl-l-carnitine chloride ()
P&D ID
PD000307
CAS
119793-66-7
Tags
available
drug candidate
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Levocarnitine propionate hydrochloride (L-Propionylcarnitine chloride) is used to study diseases such as renal function deterioration, congestive heart failure, and intermittent claudication.
PRICE
85
DESCRIPTION
Levocarnitine propionate hydrochloride (ST-261) is used for the treatment of the deterioration of renal function, congestive heart failure, intermittent claudication, and other diseases.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
5
Cayman Chemical Bioactives
ChEMBL Drugs
MedChem Express Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
20
Molecular Weight
253.11
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
6
Ring Count
0
Aromatic Ring Count
0
cLogP
-2.51
TPSA
63.6
Fraction CSP3
0.8
Chiral centers
1.0
Largest ring
0.0
QED
0.42
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
GPCR/G protein
Immunology/Inflammation
Neuroscience
Target
H1 receptor
Source data

